Historique
Bulletin de Périodique
International Journal of Drug Policy , Vol.129 - July 2024
Paru le :
01/07/2024
Langue(s) :
Anglais
Note de contenu :
CONTENTS:
- Safer-use strategies in the context of harm-reduction treatment for people experiencing homelessness and alcohol use disorder. Alawadhi Y.T., Shinagawa E., Taylor E.M., Jackson C., Fragasso A., Howard M., et al., art. 104448.
- Development of an evidence-based hepatitis C education program to enhance public health literacy in the Australian prison sector: The Hepatitis in Prisons Education program (HepPEd). Sheehan Y., Lafferty L., Tedla N., Byrne M., Dawson O., Stewart S., et al., art. 104461.
- Trends in drug overdose deaths in Mexico (1999-2019). A national descriptive analysis and interstate comparison. Ospina-Escobar A., Davila Cervantes C.A., art. 104464.
- Reducing alcohol harms whilst minimising impact on hospitality businesses: 'Sweetspot' policy options. Fitzgerald N., O'Donnell R., Uny I., Martin J.G., Cook M., Graham K., et al., art. 104465.
- 'Matters-of-concern' associated with discontinuation of long-acting injectable buprenorphine: Findings from a longitudinal qualitative study. Parkin S., Neale J., Strang J., art. 104470.
- Breaking barriers: Supporting a syndemics approach to hepatitis C elimination. Curtis M.R., Marks L., McCrary M., art. 104471.
- A content analysis of legal policy responses to xylazine in the illicit drug supply in the United States. Sugarman O.K., Shah H., Whaley S., McCourt A., Saloner B., Bandara S., art. 104472.
- The cultural turn in understanding 'addiction'. Maarefvand M., Ghiabi M., art. 104473.
- Industries, citizens, and non-governmental organizations' positioning and arguments used in European Union initiatives for alcohol taxation and cross-border regulation. Baumann S., Leao T., art. 104475.
- A systematic review of the modelling and economic evaluation studies assessing regulatory options for e-cigarette use. Collins L.G., Lindsay D., Lal A., Doan T., Schüz J., Jongenelis M., et al., art. 104476.
- Applying a stigma and time framework to facilitate equitable access to hepatitis C care among women who inject drugs: The ETHOS Engage Study. Marshall A.D., Rance J., Dore G.J., Grebely J., Treloar C., art. 104477.
- Decriminalization or police mission creep? Critical appraisal of law enforcement involvement in British Columbia, Canada's decriminalization framework. Michaud L., McDermid J., Bailey A., Singh Kelsall T., art. 104478.
- International property rights for Cannabis landraces and terroir products. The case of Moroccan Cannabis and hashish. Chouvy P.-A., art. 104479.
- Evaluation of methamphetamine assist packs: As-needed antipsychotics for self-management of methamphetamine-associated psychiatric toxicity. Coffin P.O., Chang Y.-S.G., McDaniel M., Leary M., Pating D., McMahan V.M., et al., art. 104480.
- The importance of co-produced, multi-method, independent scientific evidence in times of alternative truths and global policy debates. Comiskey C., Bergeron H., Clausen T., Colman C., Ferrer-Wreder L., Fischer G., et al., art. 104481.
- Changes in the incidence of cannabis-related disorders after the Cannabis Act and the COVID-19 pandemic in Québec, Canada. Martinez P., Huynh C., Massamba V., Zefania I., Rochette L., Vasiliadis H.-M., et al., art. 104484.
- Water, sanitation and hygiene insecurity predict abscess incidence among people who inject drugs in a binational US-Mexico metropolitan area: A longitudinal cohort study. Calderon-Villarreal A., Abramovitz D., Avelar Portillo L.J., Goldenberg S., Flanigan S., Quintana P.J.E., et al., art. 104485.
- Synergistic effects of exposure to multiple types of violence on non-fatal drug overdose among women who inject drugs in Indonesia. Stoicescu C., Medley B., Wu E., El-Bassel N., Tanjung P., Gilbert L., art. 104486.
- Comparing methadone policy and practice in France and the US: Implications for US policy reform. Englander H., Chappuy M., Krawczyck N., Bratberg J., Potee R., Jauffret-Roustide M., et al., art. 104487.
- Modelling the impacts of volumetric and minimum unit pricing for alcohol on social harms in Australia. Marzan M.B., Callinan S., Livingston M., Jiang H., art. 104502.
- Structural violence and necropolitics among Indigenous Peoples living with HIV who use substances in the Prairie provinces during COVID-19. Moore S., Christianson T., Souleymanov R., art. 104503.
- Safer-use strategies in the context of harm-reduction treatment for people experiencing homelessness and alcohol use disorder. Alawadhi Y.T., Shinagawa E., Taylor E.M., Jackson C., Fragasso A., Howard M., et al., art. 104448.
- Development of an evidence-based hepatitis C education program to enhance public health literacy in the Australian prison sector: The Hepatitis in Prisons Education program (HepPEd). Sheehan Y., Lafferty L., Tedla N., Byrne M., Dawson O., Stewart S., et al., art. 104461.
- Trends in drug overdose deaths in Mexico (1999-2019). A national descriptive analysis and interstate comparison. Ospina-Escobar A., Davila Cervantes C.A., art. 104464.
- Reducing alcohol harms whilst minimising impact on hospitality businesses: 'Sweetspot' policy options. Fitzgerald N., O'Donnell R., Uny I., Martin J.G., Cook M., Graham K., et al., art. 104465.
- 'Matters-of-concern' associated with discontinuation of long-acting injectable buprenorphine: Findings from a longitudinal qualitative study. Parkin S., Neale J., Strang J., art. 104470.
- Breaking barriers: Supporting a syndemics approach to hepatitis C elimination. Curtis M.R., Marks L., McCrary M., art. 104471.
- A content analysis of legal policy responses to xylazine in the illicit drug supply in the United States. Sugarman O.K., Shah H., Whaley S., McCourt A., Saloner B., Bandara S., art. 104472.
- The cultural turn in understanding 'addiction'. Maarefvand M., Ghiabi M., art. 104473.
- Industries, citizens, and non-governmental organizations' positioning and arguments used in European Union initiatives for alcohol taxation and cross-border regulation. Baumann S., Leao T., art. 104475.
- A systematic review of the modelling and economic evaluation studies assessing regulatory options for e-cigarette use. Collins L.G., Lindsay D., Lal A., Doan T., Schüz J., Jongenelis M., et al., art. 104476.
- Applying a stigma and time framework to facilitate equitable access to hepatitis C care among women who inject drugs: The ETHOS Engage Study. Marshall A.D., Rance J., Dore G.J., Grebely J., Treloar C., art. 104477.
- Decriminalization or police mission creep? Critical appraisal of law enforcement involvement in British Columbia, Canada's decriminalization framework. Michaud L., McDermid J., Bailey A., Singh Kelsall T., art. 104478.
- International property rights for Cannabis landraces and terroir products. The case of Moroccan Cannabis and hashish. Chouvy P.-A., art. 104479.
- Evaluation of methamphetamine assist packs: As-needed antipsychotics for self-management of methamphetamine-associated psychiatric toxicity. Coffin P.O., Chang Y.-S.G., McDaniel M., Leary M., Pating D., McMahan V.M., et al., art. 104480.
- The importance of co-produced, multi-method, independent scientific evidence in times of alternative truths and global policy debates. Comiskey C., Bergeron H., Clausen T., Colman C., Ferrer-Wreder L., Fischer G., et al., art. 104481.
- Changes in the incidence of cannabis-related disorders after the Cannabis Act and the COVID-19 pandemic in Québec, Canada. Martinez P., Huynh C., Massamba V., Zefania I., Rochette L., Vasiliadis H.-M., et al., art. 104484.
- Water, sanitation and hygiene insecurity predict abscess incidence among people who inject drugs in a binational US-Mexico metropolitan area: A longitudinal cohort study. Calderon-Villarreal A., Abramovitz D., Avelar Portillo L.J., Goldenberg S., Flanigan S., Quintana P.J.E., et al., art. 104485.
- Synergistic effects of exposure to multiple types of violence on non-fatal drug overdose among women who inject drugs in Indonesia. Stoicescu C., Medley B., Wu E., El-Bassel N., Tanjung P., Gilbert L., art. 104486.
- Comparing methadone policy and practice in France and the US: Implications for US policy reform. Englander H., Chappuy M., Krawczyck N., Bratberg J., Potee R., Jauffret-Roustide M., et al., art. 104487.
- Modelling the impacts of volumetric and minimum unit pricing for alcohol on social harms in Australia. Marzan M.B., Callinan S., Livingston M., Jiang H., art. 104502.
- Structural violence and necropolitics among Indigenous Peoples living with HIV who use substances in the Prairie provinces during COVID-19. Moore S., Christianson T., Souleymanov R., art. 104503.
Exemplaires
| Disponibilité |
|---|
| aucun exemplaire |
Dépouillements
Ajouter le résultat à votre sélection
Nouveauté
P. A. CHOUVY ;
P. A. CHOUVY
|
2024
Dans International Journal of Drug Policy (Vol.129, July 2024) Article : Périodique
Dans International Journal of Drug Policy (Vol.129, July 2024) Article : Périodique
Background: In recent years, the cannabis industry has evolved from a world defined by the simplicity and ubiquity of illegality of recreational drug cannabis to a world marked by the legal and geographic complexity of ongoing depenalisation, de[...]
Nouveauté
C. COMISKEY ;
H. BERGERON ;
T. CLAUSEN ;
C. COLMAN ;
L. FERRER-WREDER ;
G. FISCHER ;
M. G. DE MATOS ;
J. H. IVERS ;
M. JAUFFRET-ROUSTIDE ;
M. LIEM ;
T. LINTONEN ;
K. MOELLER ;
I. OJANPERA ;
F. R. DE FONSECA ;
M. T. MELICH
|
2024
Dans International Journal of Drug Policy (Vol.129, July 2024) Article : Périodique
Dans International Journal of Drug Policy (Vol.129, July 2024) Article : Périodique
In July 2024 the long established and trusted European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) will cease to exist and will evolve to the new European Drugs Agency (EUDA). In response to the ever diversifying, innovative and comp[...]
Nouveauté
H. ENGLANDER ;
M. CHAPPUY ;
N. KRAWCZYCK ;
J. BRATBERG ;
R. POTEE ;
M. JAUFFRET-ROUSTIDE ;
B. ROLLAND
|
2024
Dans International Journal of Drug Policy (Vol.129, July 2024) Article : Périodique
Dans International Journal of Drug Policy (Vol.129, July 2024) Article : Périodique
Despite being among the most effective treatments for opioid use disorder, methadone is largely unavailable in the United States, due primarily to federal and other policies that limit its availability and regulate clinical decisions about doses[...]